Applicant, as named in the Orange Book

Eagle Pharms

Next listed expiry: Belrapzo on 11 Aug 2031. 3 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Belrapzo bendamustine hydrochloride	bendamustine hydrochloride	205580	11 Aug 2031	patent
Bendeka bendamustine hydrochloride	bendamustine hydrochloride	208194	15 Mar 2033	patent, carve-out possible
Pemfexy pemetrexed	pemetrexed	209472	19 Feb 2036	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Ryanodex dantrolene sodium	dantrolene sodium	205579	open now	no listed protection